Growing community of inventors

Berlin, Germany

Michael Sefkow

Average Co-Inventor Count = 5.08

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 14

Michael SefkowMathias Dreger (2 patents)Michael SefkowRainer Wingen (1 patent)Michael SefkowGunter Scherowsky (1 patent)Michael SefkowGerd Illian (1 patent)Michael SefkowThomas Lenz (1 patent)Michael SefkowChristian Dalhoff (1 patent)Michael SefkowFriedrich Kroll (1 patent)Michael SefkowLisa Von Kleist (1 patent)Michael SefkowDaniel Ohlendorf (1 patent)Michael SefkowHubert Koester (1 patent)Michael SefkowMarén Schlief (1 patent)Michael SefkowYan Luo (1 patent)Michael SefkowKathrin Bartho (1 patent)Michael SefkowSimon Michaelis (1 patent)Michael SefkowAnna K Schrey (1 patent)Michael SefkowHubert KÖSTER (0 patent)Michael SefkowMichael Sefkow (3 patents)Mathias DregerMathias Dreger (2 patents)Rainer WingenRainer Wingen (101 patents)Gunter ScherowskyGunter Scherowsky (15 patents)Gerd IllianGerd Illian (8 patents)Thomas LenzThomas Lenz (2 patents)Christian DalhoffChristian Dalhoff (2 patents)Friedrich KrollFriedrich Kroll (1 patent)Lisa Von KleistLisa Von Kleist (1 patent)Daniel OhlendorfDaniel Ohlendorf (1 patent)Hubert KoesterHubert Koester (1 patent)Marén SchliefMarén Schlief (1 patent)Yan LuoYan Luo (1 patent)Kathrin BarthoKathrin Bartho (1 patent)Simon MichaelisSimon Michaelis (1 patent)Anna K SchreyAnna K Schrey (1 patent)Hubert KÖSTERHubert KÖSTER (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,843 patents)

2. Hoechst Aktiengesellschaft (1 from 6,662 patents)

3. Caprotec Bioanalytics Gmbh (1 from 4 patents)

4. Koester, Hubert (0 patent)


3 patents:

1. 11008282 - Bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease

2. 9550978 - Isolation and functional identification of cells

3. 5310499 - Oxazolidinone derivatives, and the use thereof as dopes in

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…